Harnessing natural killer cells for the treatment of ovarian cancer

Janneke S. Hoogstad-van Evert*, Ruud Bekkers, Nelleke Ottevanger, Joop H. Jansen, Leon Massuger, Harry Dolstra

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)810-816
Number of pages7
JournalGynecologic Oncology
Volume157
Issue number3
DOIs
Publication statusPublished - Jun 2020

Keywords

  • Ovarian cancer
  • Natural killer cells
  • Immunotherapy
  • ACUTE MYELOID-LEUKEMIA
  • NK-CELL
  • INTRAPERITONEAL CHEMOTHERAPY
  • TUMOR-CELLS
  • THERAPY
  • SURVIVAL
  • BLOOD
  • IMMUNOTHERAPY
  • CYTOTOXICITY
  • LYMPHOMA

Cite this

Hoogstad-van Evert, J. S., Bekkers, R., Ottevanger, N., Jansen, J. H., Massuger, L., & Dolstra, H. (2020). Harnessing natural killer cells for the treatment of ovarian cancer. Gynecologic Oncology, 157(3), 810-816. https://doi.org/10.1016/j.ygyno.2020.03.020